WO2022162499A1 - Ocular platforms and surgical tools - Google Patents
Ocular platforms and surgical tools Download PDFInfo
- Publication number
- WO2022162499A1 WO2022162499A1 PCT/IB2022/050378 IB2022050378W WO2022162499A1 WO 2022162499 A1 WO2022162499 A1 WO 2022162499A1 IB 2022050378 W IB2022050378 W IB 2022050378W WO 2022162499 A1 WO2022162499 A1 WO 2022162499A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- platform
- posterior
- framework
- eye
- anterior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/02—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors
- A61B17/0231—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/02—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors
- A61B17/0293—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors with ring member to support retractor elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/306—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/309—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using white LEDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
- A61B2090/3945—Active visible markers, e.g. light emitting diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/20—Surgical microscopes characterised by non-optical aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F2009/0035—Devices for immobilising a patient's head with respect to the instrument
Definitions
- Embodiments of the invention relate to ocular platforms and surgical tools, and for example to guidance of such surgical tools, such as retrobulbar surgical tools, via the platforms to their targeted locations on the eye.
- the human eye has several layers, including the sclera which comprises a white outer layer of the eye.
- the sclera provides support and protection to the choroid layer and to the retina which comprises the innermost layer.
- the choroid layer includes vasculature that provides oxygen and nourishment to the retina.
- the retina has a light sensitive tissue that includes light sensitive cells responsible for creating the visual information and transmitting it to the brain via axons of the retinal ganglion cells which forms the optic nerve.
- the macula which is the area of the retina responsible for visual acuity is located at the center of the retina at the anterior aspect of the posterior pole of the eye and is centered on an optic axis passing through the centers of the lens and cornea of the eye.
- a device and/or method for treating scleral staphyloma reinforcement (cross linking) to prevent and reduce the staphyloma is provided.
- a device and/or method may be provided for injecting medical materials such as drugs, devices, radioactive components, stem cells or gene carriers into precise locations in the posterior parts of the eye and to the optic nerve and adjacent structures.
- Embodiments of devices and/or methods described herein provide advantages of performing procedures, such as administration of injections (or the like), to posterior regions of the eye, which can be performed through the sclera - with a reduced likelihood of causing potential complications to ocular structures, such as retinal detachment..
- Such procedures which otherwise are performed through the anterior portion of the eye, when performing e.g. administration of injections may spread the injected material through the vitreous thus affecting not only the desired tissue but other intra and extra ocular tissues as well .
- optic nerve sheath fenestration and/or injections near or even directly into the optic nerve in accordance with the presented embodiments may spare open surgical approach of the orbit.
- FIGs. 1 and 2 schematically show an eyeball platform in accordance with an embodiment of the present invention
- FIGs. 3 and 4 schematically show an embodiment of an eyeball platform being fitted to a human eyeball
- FIG. 5 schematically shows a top view generally along an optic axis of an eye of an embodiment of an eyeball platform securely fitted to a human eyeball;
- FIG. 6 schematically shows a human eyeball in isolation when securely fitted with an embodiment of an eyeball platform
- FIG. 7 to 22 schematically show various embodiments of eyeball platforms during various surgical procedures
- FIGs. 23A, 23B, 24A and 24B schematically show an eyeball platform in accordance with an embodiment of the present invention
- FIG. 25 schematically shows a block diagram of a method of controlling advancement of a tool through the platform towards the eye
- FIGs. 26 to 30 schematically show an eyeball platform in accordance with yet another embodiment of the present invention, and embodiments of a surgical tool to be used with the various eyeball platform embodiments disclosed herein.
- FIG. 26 to 30 schematically show an eyeball platform in accordance with yet another embodiment of the present invention, and embodiments of a surgical tool to be used with the various eyeball platform embodiments disclosed herein.
- FIGs. 1 and 2 schematically show an eyeball platform 10 in accordance with an embodiment of the present invention.
- Platform 10 in this example is shown having a framework 11 generally formed about a central axis X that defines opposing anterior and posterior axial directions.
- Framework 11 may substantially enclose a space surrounding axis X or may lie on, or form a skeletal structure substantially included in, an imaginary surface that encloses a space surrounding axis X. In the views provided herein the latter is shown.
- Surfaces defined by framework 11 may be suited to form a substantial unobstructed line of sight along axis X and thus along a visual axis of an eye being examined/observed/treated by a physician through platform 10.
- Such surfaces may take form of various shapes, such as cylindrical, funnel, coned (and the like).
- framework 11 is embodied as a generally funnel or coned shaped formation that is formed about axis X and converges/tapers in the posterior direction.
- such funnel or coned formation may optionally be embodied by a series of axially spaced apart ring-like members that diminish in diameter in the posterior direction, and are generally parallel one to the other.
- respective angles between such ring-like members can be adjusted in relation to an imaginary plane perpendicular to axis X and/or about axis X.
- the coned formation includes a series of three ring-like members, namely a base ring member 12 at an anterior side of the framework or platform, a terminal ring member 14 at a posterior side of the framework or platform, and an intermediate ring member 16 that in this example is located more proximal to the terminal ring member 14.
- the ring members are kept spaced apart in this example by shaft like spacers 17.
- a relative axial spacing between the intermediate and terminal ring members 14, 16 may be adjusted by means of a toggle 15, and a possible anchoring sheath 18 may be located about the intermediate ring member 16, while being attached to the intermediate ring member.
- Platform 10 in addition includes an introducing channel or conduit 20 (from hereon referred to as “conduit”) and an adjustment mechanism 22 that is fitted adjacent to the base ring member 12 and is adapted to adjust an orientation of the conduit 20 within the framework 11.
- the adjustment mechanism 22 includes first and second biasing members 221, 222 that are arranged to bias and/or adjust the orientation of conduit 20 along two generally perpendicular first and second axes B1, B2 relative to framework 11.
- the first biasing member 221 may be adapted to move conduit 20 in a generally radial direction along axis B1 relative to the base ring member and by that possibly urge tilting of the conduit generally along axis B1.
- the second biasing member 222 may be adapted to move conduit 20 in a generally tangential direction relative to the base ring member along axis B2 and by that possibly urge tilting of the conduit generally along axis B2.
- FIG. 2 illustrates the conduit 20 being slightly tilted by the first biasing member 221 relative to the orientation of the conduit 20 as seen in Fig. 1.
- conduit 20 can be seen extending along an S curve that may be designed to have varying curvatures in a non-deformed state.
- Conduit 20 may include a first section 201 that may be generally straight, which transitions in a posterior direction into a second section 202 that may be designed to have an increased curvature that extends away from axis X.
- a rate of change of the curvature of the second section may initially increase as it extends away from the first section in the posterior direction and may then gradually decrease before possibly curving in an opposing direction (not shown in Fig. 2).
- the adjustment mechanism 22 may be adapted to bear against the conduit 20 at a location along the conduit’s first section 201 in order to alter the conduit's orientation relative to the coned formation of the framework 11.
- the first section 201 of the conduit may be oriented generally transverse to the platform’s axis X possibly slanting in a general posterior direction towards axis X until transitioning into second section 202 that slants in a general opposite direction away from axis X as the second section 202 of the conduit advances in the posterior direction.
- FIG. 23A, 23B, 24A and 24B Attention is drawn to figs. 23A, 23B, 24A and 24B to provide views of an embodiment of a platform 100, generally similar to platform 10.
- the views provided with respect to platform 100 reveal the maimer in which the conduit 20 may be anchored/hinged at its lower side to framework 11.
- the platform is seen being provided with a hinge arrangement 24 that is arranged to secure a lower/posterior region of the conduit 20 at a pivot 241 that remains substantially fixed in place relative to the framework of the platform.
- the platform’s pivot 241 may be arranged to be situated generally at the location of an incision formed in the Tenon capsule through which the conduit enters the subtenon space underneath the Tenon capsule (see incision 88 indicated in Fig. 4).
- situating the pivot 241 in that position reduces the likelihood of pulling out from the subtenon space or from causing further damage to the Tenon capsule as the conduit20 is tilted.
- the hinge arrangement 24 in this example includes an arm 242 that is fixed at its upper/anterior end to intermediate ring member 16 and includes pivot 241 at its lower/posterior end.
- pivot 241 may take form of a “spherical bearing” that permits angular rotation about a central point in two orthogonal directions. Also seen in Figs. 24 is the provision of an opening 33 within terminal ring member 14 through which the conduit 20 is arranged to pass.
- toggles 15, 221, 222 are shown possibly being arranged for manual manipulation by a physician, however in other embodiments (not shown) the toggles may be manipulated by a controller.
- control may be implemented as an open loop control system or as a closed loop control system as illustrated by the block diagram provided in Fig. 25.
- Block 1001 illustrates an initial step of the method where a ‘target position’ is set for a tool introduced through a platform such as 10, 100 (or 1000 disclosed herein below).
- target position may be a staphyloma, an optic nerve or any posteriorly located adjacent structures.
- the possible subsequent steps described in method 1000 may be aimed at adjusting (possibly continuously adjusting) a ‘tip position’ 1006 of the tool until it reaches the ‘target position’.
- a controller that receives the ‘target position’ may be arranged in a subsequent step 1003 to activate actuators/toggles controlling tilting of the conduit and possibly advancement of a tool being introduced through the conduit towards the eye.
- An imaging device for direct visualization of the posterior pole such as a microscope, or indirect imaging modalities such as ultrasound or oct may detect the exact position of the surgical tool tip by visualization of the trunsillumination produced by the instruments tip which may be equipped with lighting source enabling transillumination of the adjacent tissue or via indentation of the sclera with a flexible tip or detected by the indirect modalities listed above, in a subsequent step 1004, such detection may then be communicated, possibly via an Al system in step 1005 - so that a true position of the tool is received at the controller. This loop may continue until the ‘tip position’ generally matches the ‘target position’. [038] Attention is drawn to Fig.
- FIG. 3 and 4 illustrating possible steps that may be taken in order to assume an anchored state of the platform 10 to an eyeball of a patient.
- the platform in the anchored state the platform may be engaged with the eyeball via the framework’s terminal ring member 14.
- Substantial secure anchoring to the eyeball may be assisted by vacuum attachment means located at terminal ring member 14 and/or by any other suitable means such as pins that attach to the tissue of the eyeball (or the like).
- the anchoring sheath 18 possibly included in the platform may be suitably placed on surrounding facial regions, possibly adhered (e.g. self-adhered) to the skin of the patient by adhesive included upon sheath 18 and/or added to the sheath - to thus stabilize the platform in its anchored position with the aid of the skeletal orbital rim and/or facial bones.
- a posterior tip section 77 of the conduit in the anchored state of the platform, may be arranged to pass through an incision 88 formed in the Tenon capsule to be situated below the Tenon capsule, which envelopes the eyeball.
- Fig. 5 showing a top view generally along an optic axis of an eye of platform 10 in its anchored state.
- a surgeon attaching the platform to an eyeball of a patient may be guided to generally align axis X of the platform to the optic axis of the eye, and therefore axis X may be taken to also represent the eye’s optic axis.
- the generally coned formation of the platform together with the curvature of the conduit provide for a substantially un-obstructed line of the sight of the fundus of the eye to a surgeon treating the patient.
- the conduit accordingly assists in providing such a non-obstructed line of sight of the eye by initially slanting along its first section 201 in the posterior direction towards axis X and then slants along its second section 202 in an opposite direction away from axis
- FIG. 6 Attention is drawn to Fig. 6 illustrating the eyeball in isolation when securely fitted with the platform. Also seen in this view is a tip 99 of a surgical tool that advances out of the posterior tip section 77 of the conduit
- Figs. 7 to 10 illustrate a possible route of advancement of tip 99 of a primary tool while possibly employing transillumination technique for tracking the tip possibly via a microscope observing the fundus of the eye through the platform generally along axis X.
- the route of advancement may be towards a staphyloma (see indicated as 55 in Fig. 9) or any other treatment zone.
- An additional secondary tool that may be advanced via the primary tool, may be used for various treatments, such as scleral crosslinking by juxta and or/intra-scleral injection of a drag or chemical (see, e.g. Fig. 13). Scleral crosslinking can be achieved either by utilizing UV light (see, e.g. Fig. 14) or directly by the Chemical/drug. Such intra-scleral injection may possibly be achieved by a secondary tool that includes inflatable microneedles at its tip (or the like).
- Fig. 15 illustrates an example of utilizing platform 10 for advancing a tool suitable for providing sub-retinal injection
- Fig. 16 illustrates an example of advancing via the conduit tool suitable for providing suprachoroidal injection.
- FIGs. 17 to 19 demonstrate advancement of a fenestration instrument towards the optic nerve possibly again using transillumination technique for tracking the tip of the instrument, in order to possibly perform optic nerve sheath fenestration (see, e.g., Figs. 18, 19).
- FIGs. 20 to 22 illustrate possibly advancement of drag delivery instruments via the platform, e.g. in order to perform drag injection adjacent the sclera for posterior scleritis (see Fig. 21), or for performing drag injection adjacent to the optic nerve for Neuritis/Neuropathy (see Fig. 21), or the like.
- FIGs. 26 and 27 schematically show an eyeball platform 1000 in accordance with an embodiment of the present invention.
- Platform 1000 has a framework 11 generally formed about a central axis X that defines opposing anterior and posterior axial directions.
- Platform 1000 as seen in addition includes an introducing channel or conduit 20 (from hereon referred to as “conduit”), that extends between an anterior section 71 and a posterior tip section 77.
- conduit 20 can be seen extending along a generally S curve that may be designed to have varying curvatures in a non-deformed state.
- Conduit 20 may include a first section (see 201 in Fig. 2) that may be generally straight, which transitions in a posterior direction into a second section (see 202 in Fig. 2) that may be designed to have an increased curvature that extends away from axis X.
- a rate of change of the curvature of the second section may initially increase as it extends away from the first section in the posterior direction and may then gradually decrease before possibly curving in an opposing direction.
- Platform 1000 may be defined as being of a ‘static’ type, in that it may be substantially devoid of any dedicated adjustment mechanism (such as e.g. 22 seen in Fig. 2) for biasing and/or adjusting the orientation of the conduit 20 in relation to the framework 11. Platform 1000 can also be seen being provided with a support 21 that may be displaced from conduit upon the framework by about 180 degrees about axis X.
- any dedicated adjustment mechanism such as e.g. 22 seen in Fig. 2
- Platform 1000 can also be seen being provided with a support 21 that may be displaced from conduit upon the framework by about 180 degrees about axis X.
- a physician anchoring platform 1000 to a patient during surgery may grasp the platform with his fingers (e.g. the thumb and middle finger, or the like), by placing them on the opposing structures of the conduit and support, in order to maneuver the platform towards its desired position on the eyeball.
- his fingers e.g. the thumb and middle finger, or the like
- An anchored state of the platform may be assisted by vacuum atachment means located at a terminal ring member 14 of the platform and/or by any other suitable means such as pins that atach to the tissue of the eyeball (or the like).
- a suction nozzle 141 in communication with the ring member may be used for creating the vacuum required for attachment to the eye (in the case that vacuum is used for assisting in attachment to the eye).
- a possible anchoring sheath 18 may be located about an intermediate ring member 16 of platform 1000, while being attached to the intermediate ring member.
- Intermediate ring member 16 as seen in this example is axially spaced apart from ring member 14 in the anterior direction.
- the anchoring sheath 18 possibly included in the platform may be suitably placed on surrounding facial regions, possibly adhered (e.g. self-adhered) to the skin of the patient by adhesive included upon sheath 18 and/or added to the sheath - to thus stabilize the platform in its anchored position with the aid of the skeletal orbital rim and/or facial bones.
- the posterior tip section 77 of the conduit may be arranged to pass through an incision formed in the Tenon capsule to be situated below the Tenon capsule, which envelopes the eyeball.
- surgical tools introduced via the conduit towards a targeted treatment zone may be guided to advance below the Tenon capsule in order to reach regions of the eyeball such as retrobulbar regions of the eye, where therapeutic or surgical treatment is required.
- Platform 1000 can be seen in these figures being used for guiding a surgical tool 13 towards such a targeted treatment zone.
- surgical tool embodiments being guided through any one of the eyeball platform embodiments described herein may be suitably designed (e.g. provided with pre-defined curvatures along their extensions) to assist in their advancement towards retrobulbar regions of the eye, while maintaining their tips in proximity (possibly close abutment proximity) to the eye (e.g. proximity to the sclera of the eye).
- the interaction of the surgical tools with the Tenon capsule may assist in obtaining such proximity to the eye.
- certain surgical tool embodiments may be equipped with guiding mechanisms for guiding the tip of the surgical tool in order to assist in obtaining such proximity to the eye, e.g. also when the tip is in retrobulbar regions of the eye.
- the proximity to the eye of guided or non-guided surgical tools may be of at least a tip region of the tool.
- surgical tool 13 may be formed having a longitudinal extension L, which in cross sections perpendicular to axis L may have a lateral extension (Le) and a height extension (He).
- the lateral extension (Le) (similar to the surgical tool embodiments already described and shown hereinbefore) - may possibly be sized to be larger than the height extension (He), for example about one and a half or twice larger (i.e. Le ⁇ ⁇ 1.5 or ⁇ 2 x He).
- Le ⁇ ⁇ 1.5 or ⁇ 2 x He Such sizing of Le to relative He may be aimed at increasing the tool’s moment of inertia so that the surgical tool may have improved resistance to twisting about its longitudinal extension L during use.
- the surgical tool 13 can be seen being advanced towards the eye with one of its sides that extends along the lateral direction being oriented to bear against the interior of the eyeball (e.g. the sclera) while being advanced below the Tenon capsule towards a targeted treatment zone.
- Having the larger sized lateral extension Le in contact with the eyeball may further assist in stabilizing and controlling a desired orientation of the surgical tool 13 as it reaches its targeted treatment zone, possibly at retrobulbar regions of the eye.
- the surgical tool 13 can be seen being formed from two tubes 131 that extend one aside the other along axis L - however other embodiments may be equally possible, such as surgical tools having generally rectangular, elliptical or other formations in their cross sections.
- Conduit 20 can be seen in this example (and also in former embodiments) as having an interior passage for the surgical tool that generally corresponds in cross section to the cross section of the surgical tool - in order to suitably guide the surgical tool towards its targeted treatment zone.
- the surgical tool 13 may include a terminal port 1 at its distal leading side that is designed to lead it towards its targeted treatment zone as the tool is advanced along the eye below the Tenon capsule.
- the surgical tool 13 can be seen with its terminal port 1 reaching a targeted treatment zone, in this example at a retrobulbar region of the eye.
- FIG. 28 Attention is drawn to Fig. 28 for a closer view of the tool’s terminal port 1 when in position upon a targeted zone of the eyeball (with the Tenon capsule not being shown in this view).
- the terminal port 1 in this example can be seen being formed upon the distal axial end of the tool, and can be seen having a flat lower side la that is adapted to contact the interior of the eyeball (e.g. sclera) and a chamfered leading side lb at its axial end that tapers towards its lower side la to meet it at a merge 1c.
- Surgical tool embodiments having such a chamfered leading side lb may be suited to advance the surgical tool to its targeted treatment zone while assisting in maintaining the orientation of the terminal port 1 with its flat lower side la pressed against the eyeball - due to substantial constant engagement of the chamfered leading side lb with the Tenon capsule it encounters as it advances towards its targeted position.
- Figs. 29 and 30 showing cross sectional views of the surgical tool’s terminal port 1 taken along a plane generally parallel to axis L of the surgical tool.
- the terminal port 1 as seen in this example may include an optical member Id.
- Optical member Id may be suited to provide illumination and/or imaging of regions adjacent the terminal port of the surgical tool.
- the optical member Id may be an LED however other options may also be possible such as a fiber optic assisted illumination and/or imaging (or the like).
- An optical member such as Id may be used for assisting in the tracking of the surgical tools tip via a microscope, as seen in the examples shown e.g. in Figs. 7 to 10.
- Surgical tool 13 can also be seen in the example as including a movable hollow needle member le that can be seen in Figs. 29 and 30 being advanced to penetrate through a layer 62 of the eye in order to reach a targeted zone 61 that is beneath layer 62.
- layer 62 may be the sclera layer of the eye and targeted zone 61 may be the Supra choroidal or subretinal spaces of the eye.
- the needle member can be seen being curved by a passage that leads it towards its distal exit point from the surgical tool, so that it is urged to extend along an axis T that is inclined relative to the surgical tool’s axis L in this distal section of the tool.
- the needle member’s tip can also be seen in this example having a relative small angle a that is formed between a chamfer or bevel 64 and an outer periphery 65 of the needle member.
- Such small angle a in some examples may be generally smaller than about 45 degrees and preferably smaller than about 25 or 15 degrees.
- a hollow passage 63 of the needle member opens out via the chamfer 63 at its tip.
- the chamfer of the tip reaches targeted zone 61 at a position where it is generally tangent to zone 61.
- the needle member is suited to release drugs, devices, radioactive components, stem cells or gene carriers (or the like) - towards the targeted zone 61 with reduced likelihood of injecting unintentionally substances into other adjacent regions of the eye, such as the choroid, retina or into the vitrous cavity - since its sharp edge is now less positioned in an ideal orientation to penetrate into such adjacent regions other than the targeted zone.
- each of the verbs, “comprise” “include” and “have”, and conjugates thereof, are used to indicate that the object or objects of the verb are not necessarily a complete listing of members, components, elements or parts of the subject or subjects of the verb.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pathology (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22745455.0A EP4284313A4 (en) | 2021-01-26 | 2022-01-18 | OCULAR PLATFORMS AND SURGICAL INSTRUMENTS |
| US18/272,680 US12551370B2 (en) | 2021-01-26 | 2022-01-18 | Ocular platforms and surgical tools |
| CN202280011654.7A CN116897031A (en) | 2021-01-26 | 2022-01-18 | Eye Platform and Surgical Tools |
| IL304582A IL304582A (en) | 2021-01-26 | 2023-07-19 | Ocular platforms and surgical tools |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163141536P | 2021-01-26 | 2021-01-26 | |
| US63/141,536 | 2021-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022162499A1 true WO2022162499A1 (en) | 2022-08-04 |
Family
ID=82654202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2022/050378 Ceased WO2022162499A1 (en) | 2021-01-26 | 2022-01-18 | Ocular platforms and surgical tools |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12551370B2 (en) |
| EP (1) | EP4284313A4 (en) |
| CN (1) | CN116897031A (en) |
| IL (1) | IL304582A (en) |
| WO (1) | WO2022162499A1 (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5213114A (en) * | 1990-10-25 | 1993-05-25 | Bailey Jr Paul F | Ophthalmologic drape and method |
| US6267752B1 (en) * | 1999-08-05 | 2001-07-31 | Medibell Medical Vision Technologies, Ltd. | Multi-functional eyelid speculum |
| WO2003053229A2 (en) * | 2001-12-10 | 2003-07-03 | Fulcrum (Medical Devices) Limited | Eye speculum |
| US20040225284A1 (en) * | 2001-01-29 | 2004-11-11 | Webb R. Kyle | Ocular fixation and stabilization device for ophthalmic surgical applications |
| US20100010468A1 (en) * | 2008-07-01 | 2010-01-14 | Bruce Becker | Retrobulbar Needle and Methods of Use |
| US20100041957A1 (en) * | 2006-11-06 | 2010-02-18 | Kurume University | Eyelids opening device with drape |
| US20100331818A1 (en) * | 2008-02-05 | 2010-12-30 | Helica Instruments Limited | Needle for ophthalmic procedures |
| US20170360605A1 (en) * | 2016-06-17 | 2017-12-21 | Janssen Biotech, Inc. | Guide Apparatus for Tangential Entry into Suprachoroidal Space |
| US20180263815A1 (en) | 2014-06-06 | 2018-09-20 | Orbit Biomedical Limited | Sub-retinal tangential needle catheter guide and introducer |
| US20190076295A1 (en) | 2017-09-11 | 2019-03-14 | Samer Jaber Bashir | Ophthalmic intra ocular access tool |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3074407A (en) | 1956-09-17 | 1963-01-22 | Marguerite Barr Moon Eye Res F | Surgical devices for keratoplasty and methods thereof |
| US4665913A (en) * | 1983-11-17 | 1987-05-19 | Lri L.P. | Method for ophthalmological surgery |
| US5817075A (en) | 1989-08-14 | 1998-10-06 | Photogenesis, Inc. | Method for preparation and transplantation of planar implants and surgical instrument therefor |
| AU677390B2 (en) | 1992-11-20 | 1997-04-24 | Shinseiro Okamoto | Cornea operating method and apparatus |
| AUPQ496500A0 (en) * | 2000-01-06 | 2000-02-03 | University Of Sydney, The | Kit |
| EP1627617B1 (en) | 2003-06-10 | 2008-08-27 | SIE AG, Surgical Instrument Engineering | Ophthalmological device for ablation of eye tissue |
| RU2244532C1 (en) | 2003-07-01 | 2005-01-20 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова | Surgical removal and photodynamic method for treating subretinal neovascular membranes |
| EP2606864B1 (en) * | 2007-06-04 | 2016-09-14 | Oraya Therapeutics, INC. | Assembly for positioning, stabilizing and treating an eye |
| DK2227257T3 (en) | 2008-01-07 | 2013-09-30 | Salutaris Medical Devices Inc | DEVICES FOR MINIMUM-INVASIVE EXTRAOCULAR RADIATION TO THE POSTERIOR PART OF THE EYE |
| WO2011163574A1 (en) * | 2010-06-25 | 2011-12-29 | Dewoolfson Bruce H | Device and method for the controlled delivery of ophthalmic solutions |
| EP3081198A1 (en) * | 2015-04-14 | 2016-10-19 | Eyevensys | Elektroporation device for the eye with a support and with a needle electrode |
| US20230346598A1 (en) * | 2015-06-03 | 2023-11-02 | Aquesys, Inc. | Ab externo intraocular shunt placement |
| US10806629B2 (en) | 2016-06-17 | 2020-10-20 | Gyroscope Therapeutics Limited | Injection device for subretinal delivery of therapeutic agent |
| WO2018237093A1 (en) * | 2017-06-20 | 2018-12-27 | Lumitex, Inc. | LIGHTING ASSEMBLY FOR USE IN EYE SURGERY |
| DE102017005874A1 (en) | 2017-06-22 | 2018-12-27 | Ulrich Schraermeyer | Apparatus and method for regulating the retinal oxygen partial pressure to physiological values by introducing gases into the retro-orbital space or vitreous body of the eye |
| US12485233B2 (en) | 2018-04-19 | 2025-12-02 | Everads Therapy Ltd. | Device for injecting a substance into an interlayer of a body tissue or organ |
-
2022
- 2022-01-18 CN CN202280011654.7A patent/CN116897031A/en active Pending
- 2022-01-18 WO PCT/IB2022/050378 patent/WO2022162499A1/en not_active Ceased
- 2022-01-18 US US18/272,680 patent/US12551370B2/en active Active
- 2022-01-18 EP EP22745455.0A patent/EP4284313A4/en active Pending
-
2023
- 2023-07-19 IL IL304582A patent/IL304582A/en unknown
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5213114A (en) * | 1990-10-25 | 1993-05-25 | Bailey Jr Paul F | Ophthalmologic drape and method |
| US6267752B1 (en) * | 1999-08-05 | 2001-07-31 | Medibell Medical Vision Technologies, Ltd. | Multi-functional eyelid speculum |
| US20040225284A1 (en) * | 2001-01-29 | 2004-11-11 | Webb R. Kyle | Ocular fixation and stabilization device for ophthalmic surgical applications |
| WO2003053229A2 (en) * | 2001-12-10 | 2003-07-03 | Fulcrum (Medical Devices) Limited | Eye speculum |
| US20100041957A1 (en) * | 2006-11-06 | 2010-02-18 | Kurume University | Eyelids opening device with drape |
| US20100331818A1 (en) * | 2008-02-05 | 2010-12-30 | Helica Instruments Limited | Needle for ophthalmic procedures |
| US20100010468A1 (en) * | 2008-07-01 | 2010-01-14 | Bruce Becker | Retrobulbar Needle and Methods of Use |
| US20180263815A1 (en) | 2014-06-06 | 2018-09-20 | Orbit Biomedical Limited | Sub-retinal tangential needle catheter guide and introducer |
| US20170360605A1 (en) * | 2016-06-17 | 2017-12-21 | Janssen Biotech, Inc. | Guide Apparatus for Tangential Entry into Suprachoroidal Space |
| US20190076295A1 (en) | 2017-09-11 | 2019-03-14 | Samer Jaber Bashir | Ophthalmic intra ocular access tool |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP4284313A4 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116897031A (en) | 2023-10-17 |
| EP4284313A4 (en) | 2024-08-21 |
| EP4284313A1 (en) | 2023-12-06 |
| US12551370B2 (en) | 2026-02-17 |
| US20240299214A1 (en) | 2024-09-12 |
| IL304582A (en) | 2023-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220288306A1 (en) | Apparatus for subretinal administration of therapeutic agent via a curved needle | |
| US20230355432A1 (en) | Sub-retinal tangential needle catheter guide and introducer | |
| EP1615604B1 (en) | Opthalmic microsurgical instruments | |
| NL2002379C2 (en) | An ophthalmic device and an intravitreal method. | |
| JP2024540022A (en) | Methods for administration of drugs to the retina - Patents.com | |
| US12551370B2 (en) | Ocular platforms and surgical tools | |
| TW202415354A (en) | Ocular needle guide and method to facilitate access to an eye | |
| EP3682856B1 (en) | Device suitable for intraocular administration of a substance, for example a medication, into a human or animal eye | |
| CN120605161A (en) | A pre-curved needle suitable for fundus microsurgery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22745455 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 202280011654.7 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202327053221 Country of ref document: IN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2022745455 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 11202305567V Country of ref document: SG |
|
| ENP | Entry into the national phase |
Ref document number: 2022745455 Country of ref document: EP Effective date: 20230828 |